Multi-center Application of Quantitative FIT Technology in Colorectal Cancer Screening
NCT ID: NCT04959617
Last Updated: 2021-11-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500000 participants
OBSERVATIONAL
2019-01-06
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quantitative Fecal Immunochemical Test (qFIT)
The study only included quantitative FIT examination in the general physical examination population over 30 years old.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. No history of gastrointestinal tumor;
3. No ulcerative colitis or Crohn's disease;
4. No gastrointestinal hemorrhagic disease;
5. No history of gastrointestinal surgery, able to understand and willing to sign informed consent.
Exclusion Criteria
2. Patients with gastric and esophageal cancer and other malignant tumors;
3. Unable to cooperate after communication;
4. Subjects who have received radiotherapy and chemotherapy;
5. Other researchers believe that they are not suitable for inclusion in this clinical trial, such as mental illness patients, critical patients, pregnant women, illiterate minors, cognitive impairment PI, students of the researcher, PI, affiliated research units of the co-investigator or employees of the sponsor, etc
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Affiliated Hospital of Anhui Medical University
OTHER
The Second Hospital of Anhui Medical University
OTHER
The First Hospital of Jilin University
OTHER
Sino-Japanese Friendship Hospital of Jilin University
UNKNOWN
First Hospital of China Medical University
OTHER
The First Affiliated Hospital of Dalian Medical University
OTHER
The Second Affiliated Hospital of Dalian Medical University
OTHER
The Second Hospital of Hebei Medical University
OTHER
The First Hospital of Hebei Medical University
OTHER
Jiangsu Provincial People's Hospital
OTHER
The Second Hospital of Nanjing Medical University
OTHER
Jiangxi Provincial People's Hopital
OTHER
Second Affiliated Hospital of Nanchang University
OTHER
First Affiliated Hospital of Harbin Medical University
OTHER
Peking Union Medical College Hospital
OTHER
Shenzhen People's Hospital
OTHER
Guangdong Provincial People's Hospital
OTHER
Tongji Hospital
OTHER
First Affiliated Hospital of Suzhou Medical College
OTHER
Chinese PLA General Hospital
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
The First Affiliated Hospital of Inner Mongolia Medical College
UNKNOWN
Bethune International Peace Hospital
OTHER
Xinqiao Hospital of Chongqing
OTHER
Renmin Hospital of Wuhan University
OTHER
The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yingying Yu, Dr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-181
Identifier Type: -
Identifier Source: org_study_id